FIELD: medicine, virology, pharmacy. SUBSTANCE: invention proposes a composition for treatment of viral infections. The composition shows an antiviral effect and has (2R,cis)-4-amino-1-(2-hydroxy- -methyl-1,3-oxathiolan-5-yl)-1H-pyrimidine-2-one or its pharmaceutically acceptable derivative and 3'-azido-3'-deoxy-thymidine or its pharmaceutically acceptable derivative. This composition shows synergism with respect to an antiviral effect. Pharmaceutical composition comprises the indicated combination and a pharmaceutically acceptable carrier. Method of treatment of mammal or human infected or sensitive to HIV-infection is carried out by the simultaneous administration of the indicated composition consisting of two compounds - (2R, cis)- -4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimidine- -2-one and 3'-azido-3'-deoxythimidine or their derivatives or by successive administration of these compounds. EFFECT: decreased toxicity, enhanced effectiveness of treatment. 10 cl, 1 dwg, 2 tbl, 5 ex
Title |
Year |
Author |
Number |
(-)-CIS-4-AMINO-1-(2-OXYMETHYL-1,3-OXATHIOLAN-5-YL-(1H)-PYRIMIDINE-2-ON IN CRYSTALLINE FORMS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION |
1992 |
- Pol Ravenskroft[Gb]
- Toni Gordon Roberts[Gb]
- Pol Ehvans[Gb]
|
RU2102393C1 |
(-)-ENANTIOMER OF CIS-4-AMINO-1-(2-HYDROXYMETHYL-1,3-OXATHIOLAN-5-YL)-(1H)-PYRIMIDINE-2-ONE, A MIXTURE OF (-)-ENANTIOMER AND (+)-ENANTIOMER, METHOD OF THEIR PREPARING |
1991 |
- Dzhonatan Alan Viktor Kouts[Gb]
- Jan Martin Mattn[Gb]
- Charl'Z Richard Penn[Gb]
- Richard Storer[Gb]
- Kristofer Uil'Jamson[Gb]
|
RU2099338C1 |
(-)-4-AMINO-5-FLUORO-1-(2-HYDROXYMETHYL-1,3-OXATHIOLANE-5-YL)- -(1H)-PYRIMIDINE-2-ONE, A MIXTURE OF ITS ENANTIOMERS, METHODS OF THEIR SYNTHESIS, A METHOD OF TREATMENT |
1992 |
|
RU2126405C1 |
SYNERGISTIC PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OR PROPHYLAXIS OF HIV-INFECTION |
1992 |
- Dzhordzh Robert Pejnter[Us]
- Filip Allen Furman[Us]
|
RU2110993C1 |
1,3-OXATHIOLANE, GEOMETRICAL AND OPTICAL ISOMERS THEREOF, MIXTURES OF SAID ISOMERS, METHODS OF PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION HAVING ANTIVIRAL ACTIVITY |
1990 |
- Bernar Bello[Ca]
- P'Erett Bello[Ca]
- Nge Nguen-Ba[Ca]
|
RU2092485C1 |
METHOD OF TREATMENT OF PATIENTS WITH INFECTIONS INDUCED BY HEPATITIS B VIRUS |
1993 |
|
RU2157215C2 |
STEREOSELECTIVE METHOD OF PREPARING COMPOUNDS, METHODS OF INCREASING YIELD OF TRANS-ISOMERS, AND SALICYLATES OF COMPOUNDS |
1995 |
- Gudjir Majkl Dejvid
- Duajer P. Ouehn
- Khill Mehlkolm Lejtkhed
- Uajtkhed Ehndrju Dzhonatan
- Khornbi Roj
- Khehllett Piter
|
RU2158736C2 |
2,6-DIAMINOPURINE--β--D-RIBOFURANURONAMIDE DERIVATIVES, METHOD OF PREPARING THEREOF, PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ACTIVITY OF LEUKOCYTES, METHOD OF PREPARING PHARMACEUTICAL COMPOSITION, AND METHOD OF SUPPRESSING LEUKOCYTES |
1994 |
- Gregson Majkl
- Ehjrz Berri Ehdvard
- Ivan Dzhordzh Blehng
- Ehllis Frehnk
- Najt Dzhon
|
RU2129561C1 |
METHOD OF INHIBITION OF HEPATITIS B VIRAL INFECTIONS |
1992 |
- Dzhordzh Robert Pejnter Iii
- Filip Allen Furman
|
RU2116789C1 |
METHOD OF HEPATITIS B TREATMENT |
1992 |
- Fillip Allen Furman
- Dzhordzh Robert Pejnter Iii[Us]
|
RU2104700C1 |